News

Stay up to date on our latest stories.

Filters

Hikma receives approval for colchicine 0.6mg capsules

Press Release, Product
Hikma receives approval for colchicine 0.6mg capsules

Hikma Meet the Management Day

Press Release, Corporate
Hikma Meet the Management Day

Hikma completes acquisition of Ben Venue manufacturing site

Press Release, Corporate
Hikma completes acquisition of Ben Venue manufacturing site

Hikma Pharmaceuticals Interim Results

Press Release, Corporate
Hikma Pharmaceuticals Interim Results

Notice of Interim Results Announcement – Analyst Presentation

Press Release, Corporate
Notice of Interim Results Announcement – Analyst Presentation

Hikma agrees to acquire Ben Venue manufacturing site adding R&D capabilities and capacity

Press Release, Corporate
Hikma agrees to acquire Ben Venue manufacturing site adding R&D capabilities and capacity

Hikma completes the acquisition of assets of Bedford Laboratories

Press Release, Corporate
Hikma completes the acquisition of assets of Bedford Laboratories

Hikma Pharmaceuticals PLC – Acquisition of Bedford Laboratories

Press Release, Corporate
Hikma Pharmaceuticals PLC – Acquisition of Bedford Laboratories

Interim Management Statement - May 2014

Press Release, Corporate
Interim Management Statement - May 2014

Hikma announces successful resolution to US FDA warning letter at Eatontown facility

Press Release, Corporate
Hikma announces successful resolution to US FDA warning letter at Eatontown facility

Hikma Holds its 7th Volunteering Day

Press Release, Responsibility
Hikma Holds its 7th Volunteering Day

Hikma and AUB collaborate on developing anticancer treatment from medicinal plants

Press Release, Product
Hikma and AUB collaborate on developing anticancer treatment from medicinal plants

Hikma Pharmaceuticals supports and takes part in 'Earth Hour 2014'

Press Release, Corporate
Hikma Pharmaceuticals supports and takes part in 'Earth Hour 2014'

Notice of Prelim Results Announcement – Analyst Presentation

Press Release, Corporate
Notice of Prelim Results Announcement – Analyst Presentation

Hikma signs license and supply agreement with SK Chemicals for its Rivastigmine transdermal patch

Press Release, Product
Hikma signs license and supply agreement with SK Chemicals for its Rivastigmine transdermal patch